As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
ASX blue-chip shares could be some of the best investments we can make right now as investors look for safety and potential ...
The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...
Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year ...
ADT provides home security and alarm systems with devices like entry sensors, motion detection, smoke alarms and leak detectors to help ensure your home, family and belongings are protected from ...
CLEVELAND – Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be ...
Private jets are to be taxed from 2028 as part of a shake-up of how air passengers are charged in Scotland, Finance Secretary ...
Security M&A driven by strategic forces, not just interest rates: Valuation gaps, tariff volatility, and technology ...
Milliman MedInsight ® (MedInsight), a leading healthcare data and analytics division of Milliman, is entering 2026 with ...
CES brought a crowd of security companies, all vying to impress with new cameras, sensors and locks. But here's what really ...
Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, 'Telix”) today announces that the first patient in the United States (U ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback